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Abstract Intracellular oxidative stress was measured in cul-
tured human umbilical vein or bovine aortic endothelial cells 
exposed to hydrogen peroxide using an oxidation-sensitive vital 
dye, 2',7'-dichlorofluorescein, and flow cytometry. Vascular 
endothelial growth factor (VEGF), acidic fibroblast growth 
factor (aFGF) or basic fibroblast growth factor (bFGF) caused 
both a 5-10-fold increase in resistance to hydrogen peroxide 
induced fluorescence and an increase in intracellular reduced 
glutathione concentration. Increased resistance to oxidative 
stress mediated by growth factors is likely to be biologically 
relevant, and may open new avenues for therapeutic protection 
against oxidative stress. 
© 1997 Federation of European Biochemical Societies. 
Key words: Endothel ium; Oxidative damage; Vascular 
endothelial growth factor; Fibroblast growth factor, acidic; 
Fibroblast growth factor, basic; Glutathione 
1. Introduction 
Oxidative stress has been suggested as a possible cause of 
endothelial damage in a variety of situations including athe-
roma, reperfusion injury and endotoxic shock [1-3]. Endothe-
lial defence against oxidative damage is mediated by a variety 
of mechanisms including glutathione peroxidase/reduced glu-
ta th ione /NADPH, with N A D P H being generated by the pen-
tose phosphate pathway [4,5]. We measured endothelial intra-
cellular peroxidative activity using flow cytometry and the 
vital dye 2,7-dichlorofluorescein diacetate (DCF-DA) [6] in 
cultured bovine aortic endothelial cells (BAEC) and human 
umbilical vein endothelial cells (HUVEC) exposed to low con-
centrations of hydrogen peroxide. H u m a n endothelial cells in 
culture were apparently much more resistant to oxidative 
stress than bovine cells. Systematic analysis of differences in 
the culture conditions used for BAEC and H U V E C identified 
bovine brain extract (BBE) as a factor capable of upregulating 
bovine endothelial resistance to hydrogen peroxide-induced 
fluorescence. In this paper we show that the effect of BBE 
can be replicated by recombinant vascular endothelial growth 
factor (VEGF), acidic fibroblast growth factor ( aFGF) or 
basic fibroblast growth factor (bFGF) , and correlate changes 
in resistance to hydrogen peroxide-induced fluorescence with 
changes in cellular reduced glutathione (GSH) content. Clin-
ically, it may be possible to increase the resistance of endo-
thelium to oxidative stress by upregulating 'active defence' 
mechanisms such as the glutathione/glutathione peroxidase/ 
N A D P H system as well as by exogenous antioxidant supple-
mentation. 
Corresponding author. Fax (44) (116) 2875792. 
2. Materials and methods 
BAEC were obtained by collagenase digestion of fresh aortas, 
cloned to prevent contamination with smooth muscle cells or fibro-
blasts [7], and maintained in Dulbecco's modified Eagle's medium 
(DMEM) with 10% fetal calf serum (FCS) (both from Gibco) unless 
otherwise specified. Cells were subcultured every 3-5 days using 0.05% 
w/v trypsin/1 mM EDTA (Clonetics) at a 1:3 or 1:4 split ratio. HU-
VEC were also obtained by collagenase digestion and were cultured in 
Clonetics EGM, which is an Eagles-based medium supplemented with 
insulin, hydrocortisone, heparin, selenium, bovine brain extract (BBE) 
and 10% fetal calf serum. HUVEC were subcultured at 3-7 day in-
tervals with a 1:2 split ratio. Gas phase was 95% air/5%> C0 2 for all 
cultures. Cells were characterised as endothelial by light and electron 
microscopic morphology, and by their expression of endothelium-spe-
cific antigens including von Willebrand factor. 
Intracellular peroxide was measured by a modification of the tech-
nique of Carter et al. [6]. Endothelial monolayers were resuspended as 
single cells using trypsin-EDTA and washed. Cell suspensions at 106/ 
ml in Hanks' saline were preincubated with 2 uM DCF-DA for 30 
min at 37°C and 2 ug/ml propidium iodide (Sigma) for 10 min at 
37°C. (Propidium iodide stains the nuclei of damaged cells so that 
they can be distinguished from those with intact cell membranes.) 
Hydrogen peroxide (diluted from 30% stock solution, Sigma) was 
added to different aliquots to produce final concentrations of 5-100 
u.M. DCF-DA is incorporated into lipid-rich regions of cells and 
hydrolysed to 2',7'-dichlorofluorescein by cellular esterases. In the 
presence of peroxide this is oxidised to fluorescein, which emits green 
fluorescence at 514 nm on excitation at 490 nm. At times of 1-30 min 
after the addition of hydrogen peroxide samples were analysed in a 
Becton-Dickinson FACScan flow cytometer. An argon laser operating 
at 488 nm was used for excitation, fluorescein fluorescence was de-
tected using a 530 ±30 nm band-pass filter, and propidium iodide 
fluorescence using a 630 nm long pass filter. 104 cells were analysed 
per sample, of which 5—10% were gated out using propidium iodide 
fluorescence. Data are presented as mean fluorescence per cell (stand-
ard deviation), expressed as a percentage of mean fluorescence of cells 
cultured in DMEM+10% FCS exposed to 100 uM hydrogen peroxide 
for 30 min (as internal positive control). 
Reduced glutathione (GSH) was measured by the method of Pun-
chard et al. [8], which is a microplate adaptation of Tietze's method 
[9]. Briefly, endothelial cultures in 96-well plates were washed twice 
with isotonic phosphate-buffered saline (PBS), 0.1 ml 1%> 5-sulphosa-
licylic acid added, and plates stored at —80°C. After thawing, samples 
and GSH standards (1-10 nM/ml) were diluted 1:4 with PBS/5 mM 
EDTA pH 7.5 and 0.1 ml aliquots added to an equal volume of PBS 
containing 1.5 mM 5,5'-dithio-bis (2-nitrobenzoic acid) (DTNB) and 
0.5 mM NADPH. 50 ul glutathione reductase (Sigma, 1 U/ml) was 
added to each well and absorbance measured at 405 nm at 0-10 min 
at 2-min intervals. GSH content was measured by reference to the 
standard curve. All measurements were made in octuplicate. Control 
experiments showed that neither 7V-acetylcysteine nor ascorbate (0.2 
mM) interfered with the assay under the conditions used. 
GSH concentrations were expressed as pM GSH/ng cellular DNA. 
DNA content was measured in parallel cultures using fluorescence 
developed after incubation with Cy-QUANT-GR reagent (Molecular 
Probes, USA), using excitation at 485 nm and measuring emission at 
530 nm. 
To inhibit glutathione synthesis, L-buthionine S,.R-sulphoximine 
(BSO, Sigma) was added to cultures at a final concentration of 0.1 
mM, 24 h before they were harvested for flow cytometry. In other 
experiments, ?-butyl hydroperoxide (tBHP) was added to cultures at a 
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final concentration of 5 uM, 1 h before harvesting. The antioxidants 
ascorbic acid (final concentration 0.1 mM) or JV-acetylcysteine (final 
concentration 0.1 mM) were added to cultures (where specified) 5 h or 
1 h before harvesting, and were also added at the same concentration 
to the flow cytometry buffer. 
Flow cytometry distributions were compared using the Kolmogo-
rov-Smirnov statistic; other comparisons were by 2-way analysis of 
variance with post-hoc Newman-Keuls test; P<0.05 was taken as the 
level of statistical significance. Experiments were repeated at least 
three times; data in Fig. 1 and Tables 1-3 represent typical experi-
ments. 
Recombinant human VEGF, aFGF, bFGF, t-BHP, DTNB and 
BSO were purchased from Sigma. 
3. Results 
Hydrogen peroxide caused a dose- and time-dependent in-
crease in fluorescence of DCF-DA-loaded BAEC cultured in 
DMEM+10% FCS (Table 1A, Fig. 1). tBHP (5 uM), which is 
both a substrate for and inhibitor of glutathione peroxidase, 
or previous culture in BSO-containing medium (data not 
shown) increased the fluorescence observed after exposure to 
the same concentrations of hydrogen peroxide. DCF-DA-
loaded HUVEC cultured in EGM+supplements+10% FCS 
also showed increased fluorescence when exposed to hydrogen 
peroxide, but much higher concentrations of hydrogen perox-
ide (50-200 LtM) were required to produce equivalent fluores-
cence (data not shown). Neither ascorbate nor V-acetylcys-
teine pre-incubation for 1 h affected fluorescence in response 
to hydrogen peroxide exposure (Table IB). 
BAEC cultured in DMEM+EGM supplements before 
DCF-DA loading became resistant to hydrogen peroxide-in-
duced fluorescence (Fig. 2). The factor conferring hydrogen 
peroxide resistance was identified by exclusion as BBE, and 
BBE added to DMEM+FCS increased oxidative resistance 
(Table 1C). VEGF (10 ng/ml), aFGF (10 ng/ml), or bFGF 
(2 ng/ml) increased hydrogen peroxide resistance to the same 
extent as BBE, whereas epidermal growth factor (10 ng/ml) 
Fig. 1. Time-fluorescence curves for resuspended, DCF-DA-loaded 
BAEC exposed to hydrogen peroxide. Cell suspensions at 106/ml in 
Hanks' saline were preincubated with 2 uM DCF-DA for 30 min at 
37°C and 2 ug/ml propidium iodide for 10 min at 37°C. Hydrogen 
peroxide was added to different aliquots to produce final concentra-
tions of 5-20 |J.M. At times of 1-30 min after the addition of hydro-
gen peroxide samples were analysed in a Becton-Dickinson FACS-
can flow cytometer. 104 cells were analysed per sample, of which 5-
10% were gated out as permeable or damaged cells using propidium 
iodide fluorescence. Vertical axis indicates fluorescence in arbitrary 
units. 
was ineffective. Inhibiting cell growth by reducing serum con-
tent of the medium to 2% did not block the increase in hydro-
gen peroxide resistance (Table 2). An increase in hydrogen 
peroxide resistance could be detected within 24 h of adding 
BBE or VEGF to cultures; similarly the effect is lost within 
24-48 h of transferring to DMEM+FCS (data not shown). 
Bovine aortic endothelial cells cultured in DMEM+FCS 
with the addition of BBE, VEGF bFGF or aFGF ('growth 
factors') showed higher GSH contents than BAEC cultured in 
DMEM+FCS alone (Table 3). BSO lowered basal GSH levels 
and inhibited the increase in GSH content caused by growth 
factors, but tBHP had little effect on GSH levels at 1 h, and 
Table 1 
Fluorescence of DCFH-loaded endothelial cells exposed to H2O2 (expressed as %±S.D. fluorescence of control cells 20 min after exposure to 
0.1 mM H202) 
Time: 1 min 
A. BAEC in DMEMI10% FCS; effect of H202 and tBHP 
N0H2O2 19 ±9 
H 2 0 2 5uM 31 ±15 
H 2 0 2 20uM 54 ±28 
tBHP 5uM 32 ±19 
tBHP 5(xM+H202 5uM 39 ±23 
10 min 
22 ±10 
56 ±33 
99 ±46 
68 ±48 
92 ±66 
B. Effect of N-acetylcysteine and ascorbic acid; BAEC exposed to 0.1 mM H2 02 
10% FCS 39 ±26 
NAC (0.1 mM) 37 ±27 
Ascorbic acid (0.1 mM) 32 ±21 
C. BAEC in DMEMI10% FCS+growth factors; exposed to 
No growth factors 31 ± 19 
EGF (10 ng/ml) 37 ±32 
BBE (4 |a,l/ml) 22 ±10 
aFGF (10 ng/ml) 13 ±9 
bFGF (2 ng/ml) 12 ±8 
VEGF( 10 ng/ml) 10 ±7 
86 ±48 
86 ±35 
75 ±45 
0.1 mM H202 
79 ±34 
87 ±51 
41 ±22 
39 ±26 
35 ±30 
33 ±16 
20 min 
24 ±12 
55 ±32 
100 ±43 
78 ±56 
103 ±76 
100 ±64 
99 ±63 
85 ±53 
95 ±54 
102 ±52 
47 ±28 
52 ±25 
42 ±15 
42 ±18 
/> = 0.8* 
P = 0A* 
P = 0.4 
P< 0.001 
P< 0.001 
P< 0.001 
P< 0.001 
Each block represents a separate experiment. Figures represent mean fluorescence per cell (S.D.) of viable cells at 1, 10 and 20 min after adding 
hydrogen peroxide, as a percentage of mean fluorescence of internal positive control (see text). 
A. Effect of different hydrogen peroxide concentrations+tBHP on fluorescence of BAEC grown in DMEM/10% FCS. 
B. Effects of preincubation with ascorbate or A'-acetylcysteine on DCF fluorescence of BAEC exposed to 100 uM hydrogen peroxide. 
C. Effects of different growth factors added to DMEM+10% FCS 72 h before experiment. 
* vs 10%) FCS; vs no growth factors. 
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Table 2 
Effect of cell growth rate on fluorescence of DCF-DA-loaded BAEC exposed to 100 uM H2O2 
Culture condition Cell density (cells/cm2) Fluorescence 
10% FCS 
2% FCS+BBE 
10% FCS+BBE 
1.1 X105 
0.5 X105 
1.2X105 
100 ±44 
61 ±36 
63 ±32 
}P<0.01 
}P = 0.7 
BAEC were plated at 0.4 X 105/cm2 in DMEM±BBE with either 2% or 10% FCS. Cells were harvested at 48 h, cell numbers were counted and 
mean fluorescence measured 20 min after hydrogen peroxide exposure. 2% FCS+BBE vs 10% FCS, P<0.01, 2% FCS+BBE vs 10% FCS+BBE, 
P = 0.7. 
caused only a modest fall at 5 h. Neither ascorbate nor N-
acetylcysteine significantly increased intracellular GSH after 
1 or 5 h preincubation, indeed ascorbate caused a fall in 
GSH content. 
4. Discussion 
In our experimental system, hydrogen peroxide-induced flu-
orescence in DCF-DA-loaded BAEC correlated inversely with 
GSH content. BBE, VEGF, bFGF and aFGF increased hy-
drogen peroxide resistance and simultaneously raised GSH 
levels, and both the increase in resistance and the rise in 
GSH were inhibited by BSO, which inhibits glutathione syn-
thesis. This would be compatible with a mechanism whereby 
increased GSH led to a more rapid clearance of intracellular 
H2O2 by glutathione peroxidase, and thus to lower peak 
H2O2 concentrations. Conversely, fluorescence was enhanced 
by tBHP with little change in GSH level. tBHP is a substrate 
for glutathione peroxidase, and at high concentrations may 
cause GSH depletion [10], but our results at the low tBHP 
concentration of 5 (iM would be more compatible with an 
action as an inhibitor of hydrogen peroxide reduction by glu-
tathione peroxidase. 
BBE greatly facilitates the growth of HUVEC in culture, 
particularly at low plating density [11], but is not essential for 
the culture of BAEC. It is not clear whether HUVEC are 
particularly prone to lethal oxidative damage in the absence 
of BBE, or conversely whether BAEC have alternative defence 
mechanisms : it was the ability of BAEC to survive and grow 
in the absence of BBE that made the experiments described 
above feasible. 
BBE is a source of crude VEGF and FGF [11,12]. VEGF is 
a highly conserved peptide growth factor which occurs in 
several isoforms resulting from differential splicing of a single 
gene, circulates as a homodimer, and binds to two distinct 
endothelial cell receptors [13]. It is a powerful angiogenic 
stimulus and endothelial mitogen in several different models. 
VEGF also causes a marked increase in vascular permeability. 
In the present study the up-regulation by VEGF of resistance 
to oxidative stress appeared to be distinct from a mitogenic 
effect. VEGF expression can be induced in several cell types, 
including endothelium [14] and myocardium [15], by hypoxia, 
and in lung type II alveolar cells by oxidative damage [16]. It 
has been cited as a member of a family of 'stress-induced 
genes' [17]. Vascular endothelial growth factor may also be 
induced by cytokines such as platelet-derived growth factor or 
basic fibroblast growth factor [18,19]. Despite its expression 
by such a variety of cell types, VEGF receptors are confined 
to endothelium. aFGF is also produced by cardiac myocytes 
and is thought to play a role in myocyte proliferation and 
capillary angiogenesis [20]. In bovine epithelial lens cells, up-
regulation of aFGF expression is important for the survival of 
quiescent cells, an effect which is also independent of mito-
genesis [21]. 
Endothelial oxidative stress is known to be increased under 
conditions of hypoxia/reoxygenation [1,22,23], and may be 
further increased as a result of leukocyte activation [24]. Re-
sistance to such stress may be passive, depending on other 
cells, on enzymes such as catalase and Superoxide dismutase, 
or on exogenous antioxidants from dietary sources. Alterna-
tively, 'active' defence involves the generation of reducing 
equivalents in the form of NADPH by glucose metabolism 
via the pentose phosphate pathway, in conjunction with glu-
tathione and glutathione peroxidase [4,5,25]. Reduced gluta-
thione is also important in resistance to nitric oxide induced 
cytotoxicity [26]. 
We have now shown that this active defence mechanism can 
be powerfully upregulated by specific growth factors, VEGF 
and basic or acidic FGF. The effect appears to be the phys-
iological converse of the increased oxidative sensitivity and 
Table 3 
Effect of growth factors, inhibitors and antioxidants on BAEC reduced glutathione content 
Control 
BSO (0.1 mM, 24 h) 
tBHP (5 uM, 1 h) 
tBHP (5 uM, 5 h) 
Ascorbate (0.2 mM, ] 
Ascorbate (0.2 mM, ; 
NAC (0.2 mM, 1 h) 
NAC (0.2 mM, 5 h) 
I h ) 
i h ) 
Control 
5.2 (0.5) 
2.0 (0.2) 
5.6 (1.0) 
4.2 (0.4) 
3.1 (0.4) 
3.3 (0.3) 
5.3 (0.7) 
5.6 (1.0) 
aFGF 
9.1 (0.7) 
1.9 (0.2) 
6.8 (0.8) 
6.2 (0.9) 
5.6 (0.7) 
5.0 (0.5) 
9.1 (0.5) 
6.8 (0.8) 
bFGF 
10.0 (1.0) 
2.6 (0.2) 
7.6 (0.8) 
6.6 (0.4) 
5.7 (0.7) 
5.2 (0.5) 
10.9 (0.5) 
7.6 (0.8) 
BBE 
9.1 (1.0) 
2.5 (0.2) 
8.2 (1.0) 
7.1 (6.7) 
5.4 (0.5) 
5.3 (0.5) 
10.2 (1.1) 
8.2 (1.0) 
VEGF 
8.0 (0.6) 
3.2 (0.2) 
8.0 (0.7) 
6.5 (0.5) 
5.4 (0.4) 
3.9 (0.1) 
8.2 (0.7) 
8.0 (0.7) 
P<0 .001 a 
P<0 .001 b 
P = 0.06c 
P < 0 . 0 1 c 
P < 0 . 0 1 d 
P < 0 . 0 1 d 
P = 0.2e 
P = 0.07e 
GSH content of confluent bovine aortic endothelial cells cultured in DMEM+FCS (control) or DMEM+FCS with the addition of aFGF, bFGF, 
VEGF (all at 10 ng/ml) or BBE (4 u]/ml) for 72 h. Where indicated cells were incubated before harvesting with ascorbate, JV-acetylcysteine (NAC), 
BSO or tBHP for the times and at the concentrations specified. Results are expressed as mean (n = 8) (S.E.) pM GSH per ng DNA. 
"Control (no growth factors) vs growth factors. bBSO vs control. ctBHP vs control. dAscorbate vs control. eNAC vs control. 
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Fig. 2. Dose-response curve of DCF-DA-loaded BAEC fluorescence 
against log hydrogen peroxide concentration for control cells and 
for cells cultured for 72 h with 10 ng/ml VEGF or aFGF. Fluores-
cence was measured 10 min after the addition of hydrogen peroxide. 
Vertical axis indicates fluorescence expressed as percent fluorescence 
of control cells exposed to 100 üM hydrogen peroxide for 10 min. 
glutathione depletion in response to tumor necrosis factor 
alpha described by Ishii and colleagues [4]. Fuks and col-
leagues have previously shown that bFGF increased endothe-
lial resistance to radiation-induced damage in vivo and in 
vitro [27], and GSH upregulation may be one of the mecha-
nisms involved. There is a clear teleological link between in-
creased risk of oxidative damage, increased VEGF expression, 
and upregulation of the glutathione-glutathione peroxidase 
system in response to hypoxia. The system may have a role 
in the phenomenon of myocardial 'preconditioning' by prior 
ischaemic exposure protecting against ischaemia-reperfusion 
damage. Also of interest is the potential involvement of cell-
cell cooperation, since many cell types produce VEGF but 
only endothelial cells appear to have VEGF surface receptors. 
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